MYC and B-cell non-Hodgkin lymphoma: It is very interesting that the Eμ-myc model of B-cell lymphoma, one of the earliest transgenic mice ever developed to still be widely used today [67], also showed a requirement for PI3K, but not mTOR or ERK, activity in mitogen-induced B-cell growth [68].